InsidersTradesSigma
Track the Dogwood Therapeutics, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €84.6m. The latest transaction was filed on 25 November 2025 (C). Among the most active insiders: Sealbond Ltd. The full history is free.
Analysts rate Dogwood Therapeutics, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: US$14.00.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Dogwood Therapeutics, Inc. 是一家专注于开发神经系统疾病创新疗法的公司。该公司在XNAS市场上市。